martes, 16 de junio de 2026

Safety and Efficacy of Subcutaneous Efgartigimod PH20 in Ocular Myasthenia Gravis by Madaline Spencer| Published on: Jun 16, 2026

Safety and Efficacy of Subcutaneous Efgartigimod PH20 in Ocular Myasthenia Gravis by Madaline Spencer| Published on: Jun 16, 2026 Carolina Barnett-Tapia, MD, Neuromuscular Neurologist and the University of Toronto, discusses the safety and efficacy of subcutaneous efgartigimod PH20 in ocular myasthenia gravis (oMG). https://checkrare.com/safety-and-efficacy-of-subcutaneous-efgartigimod-ph20-in-ocular-myasthenia-gravis/

No hay comentarios:

Publicar un comentario